Health Canada
- Status: approved
Stepwise therapy for dyslipidemia, hypertension and diabetes (Stepwise therapy for dyslipidemia, hypertension and diabetes) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Hospital de Sabadell is the originator. The local marketing authorisation holder may differ — check the official source linked above.